Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v6-EN
Language English English
Date Updated 2018-10-02 2018-09-21
Drug Identification Number 02244126 02244126
Brand name DOVOBET OINTMENT DOVOBET OINTMENT
Common or Proper name calcipotriol and betamethasone dipropionate calcipotriol and betamethasone dipropionate
Company Name LEO PHARMA INC LEO PHARMA INC
Ingredients BETAMETHASONE CALCIPOTRIOL BETAMETHASONE CALCIPOTRIOL
Strength(s) 0.5MG 50MCG 0.5MG 50MCG
Dosage form(s) OINTMENT OINTMENT
Route of administration TOPICAL TOPICAL
Packaging size 120g 120g
ATC code D05AX D05AX
ATC description ANTIPSORIATICS FOR TOPICAL USE ANTIPSORIATICS FOR TOPICAL USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-07-26 2018-07-26
Actual start date 2018-07-26 2018-07-26
Estimated end date 2018-10-01 2018-10-01
Actual end date 2018-10-01
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments